Design Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Carlsbad, CA
DSGN chart
What traders are saying about $DSGN
Latest postsDesign Therapeutics, Inc. news
- Design Therapeutics (DSGN) Rallies 4.32% to $11.10, Pressing Toward Upper Resistance - Bear Flag
www.dars.gov.et ·
- Nike downgraded, Airbnb upgraded: Wall Street's top analyst calls
Yahoo Finance ·
- Design Therapeutics to Participate in 2026 Cantor Fitzgerald Global Healthcare Conference
Yahoo Finance ·
- Wall Street Moves on MAA, Rivian and Design Therapeutics: One Upgrade, One Target Trim and a Biotech on Watch
247wallst.com ·
- Design Therapeutics Provides RESTORE-FA Clinical Development Update and Reports Second Quarter 2026 Financial Results
Yahoo Finance ·
- Fuchs Endothelial Corneal Dystrophy Market Forecast Highlights Significant Growth During the Forecast Period (2026-2036), Owing to the Expanding Treatment Landscape and Increasing Patient Pool | DelveInsight
Yahoo Finance ·
- Design Therapeutics Announces Initiation of Patient Dosing in Phase 1 Multiple Ascending Dose Trial of DT-818 for Myotonic Dystrophy Type-1
Yahoo Finance ·
- Are Medical Stocks Lagging Atea Pharmaceuticals (AVIR) This Year?
Yahoo Finance ·
- Protego Biopharma Appoints Jae B. Kim, MD, as Chief Medical Officer
Yahoo Finance ·
- Design Therapeutics to Participate in 2026 Jefferies Global Healthcare Conference
Yahoo Finance ·
- This Biotech Leader Ran Up As Much As 18% — And Then Lost It All
Yahoo Finance ·
- Design Therapeutics Shares Jump on Encouraging Friedreich Ataxia Trial Results (DSGN)
investorshub.advfn.com ·
Design Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $0 | $0 | – | – |
| Net income | -$69.8M | -$49.6M | -$66.9M | -$63.3M |
| Diluted EPS | $-1.22 | $-0.88 | $-1.19 | $-1.14 |
| Total assets (year end) | $226.2M | $252.1M | $289.6M | $341.1M |
| Cash and equivalents (year end) | $16.9M | $22.6M | $21.2M | $26.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Design Therapeutics, Inc.
- Ticker
- DSGN (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Carlsbad, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1807120
Frequently asked questions
What exchange is Design Therapeutics, Inc. listed on?
Design Therapeutics, Inc. trades on the Nasdaq under the ticker symbol DSGN.
What industry is Design Therapeutics, Inc. in?
Design Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Design Therapeutics, Inc. headquartered?
Design Therapeutics, Inc.'s business address on file with the SEC is in Carlsbad, CA.
When does Design Therapeutics, Inc.'s fiscal year end?
Design Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Design Therapeutics, Inc. report?
Design Therapeutics, Inc. reported $0 in revenue for calendar year 2025, according to its SEC filings.